Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
TERMINATED
NCT05029752
NA
Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
The Vendys II, an FDA-approved device, uses finger digital thermal monitoring (DTM) after a period of blood flow restriction to evaluate vascular health. This study will evaluate the feasibility of using this device to measure the Vascular Reactivity Index (VRI) in children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT).
Key Details
Gender
All
Age Range
6 Years - 26 Years
Study Type
INTERVENTIONAL
Enrollment
27
Start Date
2021-06-30
Completion Date
2025-08-29
Last Updated
2026-07-15
Healthy Volunteers
No
Interventions
DEVICE
Vendys II Device
Using the device
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States